TD Asset Management
ARIA

TD Asset Management’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

TD Asset Management’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-115,003
Closed -$1.43M – 1461
2016
Q4 		$1.43M Sell
115,003
-1,197
-1% -$14.4K ﹤0.01% 937
2016
Q3 		$1.59M Buy
+116,200
New +$1.17M ﹤0.01% 914
2013
Q3 		– Sell
-24,300
Closed -$425K – 1287
2013
Q2 		$425K Buy
+24,300
New +$431K ﹤0.01% 965

Other funds holding ARIA

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

TD Asset Management's ARIA Position: Q1 2017 in Review

TD Asset Management sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 115,003 shares — an estimated $1.43M sold.

TD Asset Management first reported a position in ARIA in Q2 2013 and held it in 3 quarters. The position peaked at $1.59M in Q3 2016. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

  • TD Asset Management reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
  • TD Asset Management sold 115,003 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $1.43M.
  • TD Asset Management first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 3 quarters.
  • TD Asset Management's Ariad Pharmaceuticals Inc position peaked at $1.59M in Q3 2016.
  • 1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on TD Asset Management's 13F filing for Q1 2017, filed 5 May 2017.